Collagenase clostridium histolyticum is under clinical development by Endo International and currently in Phase III for Unspecified Musculoskeletal Disorders.
Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.
Thus, net collagenase activity reflects the relative amounts of activated metalloproteinases and their inhibitors, especially TIMPs. WBC chemoattractant and cytokine release. Increased production ...
This narrative review examines developments in collagenase chemonucleolysis for LDH, integrating a literature analysis with clinical experience. Key advancements include the transition from ...
Next, 10 mL of enzyme solution 2 (DMEM/F-12 (GIBCO), collagenase IV(BBI), collagenase I (SANGON), dispase II (SIGMA), P/S) was added, mixed, and incubated under the same conditions for 60 min. The ...
During the development of the olfactory epithelium (OE), olfactory sensory neurons (OSNs) express only one member of the odorant receptor (OR) gene family, and O ...
Regenerative medicine has significantly impacted orthopaedic surgery by introducing biological therapies aimed at repairing, ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Impaired insulin receptor signaling is ...
Department of Cariology and Endodontology, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National ...
Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...